These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37544877)

  • 21. A case of drug reaction with eosinophilia and systemic symptoms (DRESS) without a typical precipitant.
    Griffin DW; Martin GE; McLean C; Cheng AC; Giles ML
    Med J Aust; 2020 Apr; 212(7):300-301.e1. PubMed ID: 32092152
    [No Abstract]   [Full Text] [Related]  

  • 22. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    Lee JW; Yu DA; Cho S; Youn SW; Kwon O
    J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
    de Groot AC
    Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laryngeal edema in drug reaction with eosinophilia and systemic symptoms syndrome due to sulfasalazine.
    Shimada Y; Suyama Y; Koizumi M; Hagiwara K
    Int J Rheum Dis; 2023 Nov; 26(11):2317-2319. PubMed ID: 37317785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hepatic failure in trimethoprim-induced drug rash with eosinophilia and systemic symptoms (DRESS).
    Connolly A; Walsh S; Philippidou M; Salisbury J; Creamer D
    Br J Dermatol; 2023 Jul; 189(1):140-141. PubMed ID: 36946217
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute Liver Injury in the setting of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome with Cocaine as suspected culprit agent: A case report.
    Beas R; Montrose J; Montalvan-Sanchez E; Baek JJ; Alkashash AM; Ghabril M
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):102023. PubMed ID: 36126865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.
    Gallardo MA; Mallela T; Gilkey T; Himed S; Walker TD; Nusbaum KB; Korman A; Trinidad J; Chung C; Kaffenberger BH
    J Am Acad Dermatol; 2023 May; 88(5):1142-1145. PubMed ID: 36442643
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil.
    Fargeas M; Calugareanu A; Ben-Said B
    Contact Dermatitis; 2022 Aug; 87(2):203-204. PubMed ID: 35419842
    [No Abstract]   [Full Text] [Related]  

  • 29. DRESS syndrome: a detailed insight.
    Behera SK; Das S; Xavier AS; Selvarajan S
    Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe enterocolitis associated with antiepileptic-induced drug reaction with eosinophilia and systemic symptoms.
    Swanson EA; Low L; Naini BV
    Hum Pathol; 2014 Sep; 45(9):1973-7. PubMed ID: 24935058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to: Momen et al's "Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype".
    Cheng HM; Tey HL
    J Am Acad Dermatol; 2021 Nov; 85(5):e303-e304. PubMed ID: 34302901
    [No Abstract]   [Full Text] [Related]  

  • 32. Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS).
    Chou HY; Chen CB; Cheng CY; Chen YA; Ng CY; Kuo KL; Chen WL; Chen CH
    J Clin Pharm Ther; 2015 Dec; 40(6):689-92. PubMed ID: 26365588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First case of DRESS (drug reaction with eosinophilia and systemic symptoms) associated with voxelotor.
    Lee M; Stringer T; Jacob J; Friedman EM; Minniti C; Billett HH; Curtis SA
    Am J Hematol; 2021 Nov; 96(11):E436-E439. PubMed ID: 34478170
    [No Abstract]   [Full Text] [Related]  

  • 34. Suspicion of fenofibrate-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report.
    Safrano L; Bourneau-Martin D; Le Clech C; Chennebault JM; Jamet A; Drablier G; Lagarce L; Lainé-Cessac P
    Therapie; 2014; 69(5):461-4. PubMed ID: 25269143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythema multiforme-like drug reaction with eosinophilia and systemic symptoms (DRESS).
    Hoshina D; Furuya K; Okita I
    Clin Exp Dermatol; 2015 Jun; 40(4):455-6. PubMed ID: 25545118
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.
    Mori F; Caffarelli C; Caimmi S; Bottau P; Liotti L; Franceschini F; Cardinale F; Bernardini R; Crisafulli G; Saretta F; Novembre E
    Acta Biomed; 2019 Jan; 90(3-S):66-79. PubMed ID: 30830064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.
    Lim HY; Huang GK; Torresi J; Johnson D
    J Travel Med; 2014; 21(6):425-8. PubMed ID: 25345985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Reaction With Eosinophilia and Systemic Symptoms.
    Krantz MS; Phillips EJ
    JAMA Dermatol; 2023 Mar; 159(3):348. PubMed ID: 36630118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dress syndrome in 7-year-old male child - case report.
    Prylińska M; Dworakowska-Kicińska M; Krogulska A
    J Mother Child; 2021 Jan; 24(3):45-48. PubMed ID: 33470957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.